{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:03:20Z","timestamp":1749355400103,"version":"3.41.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Brain metastases originate from other primary cancers within the body, most commonly lung, breast, and melanoma. Because patients with brain metastasis, stroke, or intracranial hemorrhage may present with similar acute neurologic symptoms, clinicians must have a high suspicion for brain metastasis and perform an immediate workup to rule out life-threatening conditions. This case report focuses on the clinical symptoms, diagnostics, and treatment options for brain metastasis in a patient with multiple malignancies.<\/jats:p>","DOI":"10.1097\/01.jaa.0000731496.45248.a6","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T04:00:15Z","timestamp":1611115215000},"page":"28-31","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Brain metastasis in a patient with multiple malignancies"],"prefix":"10.1097","volume":"34","author":[{"given":"Kevlin","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Zerfoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Rolfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"R1-20250607","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11912-009-0071-x","article-title":"Neurologic complications of cancer and its treatment","volume":"12","author":"Giglio","year":"2010","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/1078155218798176","article-title":"Preservation of cognitive function following whole brain radiotherapy in patients with brain metastases: complications, treatments, and the emerging role of memantine","volume":"25","author":"Lynch","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PPO.0000000000000237","article-title":"Melanoma brain metastases: current areas of investigation and future directions","volume":"23","author":"Glitza Oliva","year":"2017","journal-title":"Cancer J (Sudbury, Mass.)"},{"issue":"9","key":"R4-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox071","article-title":"Incidence of brain metastasis from esophageal cancer","volume":"30","author":"Welch","year":"2017","journal-title":"Dis Esophagus"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2147\/CMAR.S150350","article-title":"Sites of metastasis and overall survival in esophageal cancer: a population-based study","volume":"9","author":"Wu","year":"2017","journal-title":"Cancer Manag Res"},{"issue":"suppl 4","key":"R6-20250607","first-page":"S203","article-title":"Surgery for brain metastases","volume":"4","author":"Yaeger","year":"2013","journal-title":"Surg Neurol Int"},{"issue":"1","key":"R7-20250607","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0885066615619618","article-title":"Critical care management of cerebral edema in brain tumors","volume":"32","author":"Esquenazi","year":"2017","journal-title":"J Intensive Care Med"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fonc.2018.00161","article-title":"Mechanisms and therapy for cancer metastasis to the brain","volume":"8","author":"Franchino","year":"2018","journal-title":"Front Oncol"},{"issue":"2","key":"R9-20250607","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls","volume":"4","author":"Dietrich","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fsurg.2016.00030","article-title":"The current and future treatment of brain metastases","volume":"3","author":"Hardesty","year":"2016","journal-title":"Front Surg"},{"issue":"10","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/ijms19103054","article-title":"Stereotactic radiosurgery and immune checkpoint inhibitors in the management of brain metastases","volume":"19","author":"Lehrer","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"suppl 4","key":"R12-20250607","first-page":"S236","article-title":"Whole brain radiotherapy for brain metastasis","volume":"4","author":"McTyre","year":"2013","journal-title":"Surg Neurol Int"},{"issue":"1","key":"R13-20250607","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13014-019-1245-9","article-title":"Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases\u2014a single institution analysis","volume":"14","author":"Buecker","year":"2019","journal-title":"Radiat Oncol"},{"issue":"5","key":"R14-20250607","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4103\/jcrt.JCRT_323_17","article-title":"Efficacy and safety of temozolomide plus whole-brain radiotherapy in the treatment of intracranial metastases","volume":"13","author":"Liu","year":"2017","journal-title":"J Cancer Res Ther"},{"issue":"16","key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1200\/JCO.2014.60.1799","article-title":"Update on metastatic gastric and esophageal cancers","volume":"33","author":"Shah","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"R16-20250607","doi-asserted-by":"crossref","first-page":"699","DOI":"10.21037\/jtd.2018.01.120","article-title":"Immune checkpoint blockade therapy for esophageal squamous cell carcinoma","volume":"10","author":"Harada","year":"2018","journal-title":"J Thorac Dis"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000731496.45248.a6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:01:37Z","timestamp":1749322897000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000731496.45248.a6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000731496.45248.a6","relation":{},"ISSN":["1547-1896"],"issn-type":[{"type":"print","value":"1547-1896"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}